SHUTTLE PHARMACEUTICALS HOLDINGS INC (SHPH)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-05
$5.04-3.26%
Close 2026-11-05 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-05
QuarterlyIQ Insights · SHPH
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Gaithersburg, Maryland – (June 25, 2026) – United Dogecoin Inc. (“United Dogecoin” or the “Company”), a Dogecoin mining and digital infrastructure company driven by industry experts recently acquired…
Stated in a supplied disclosure. Management reported: “Gaithersburg, Maryland – (June 25, 2026) – United Dogecoin Inc. (“United Dogecoin” or the “Company”), a Dogecoin mining and digital infrastructure company driven by industry experts recently acquired by Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) (“Shuttle”) (NASDAQ: SHPH), has initiated an evaluation of proprietary data centre and power generation opportunities designed to support long-term DOGE mining operations and future AI infrastructure workloads.” “In parallel, United Dogecoin remains focused on energizing its first ElphaPex miners as the units arrive at the Company’s hosting facility.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated weak grew net income 29% of the time over the next year (vs 52% for the rest of the cohort, n=10118).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Exhibit 99.1 Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter Gaithersburg, Maryland, August 28, 2026, Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (th…
Stated in a supplied disclosure. Management reported: “Exhibit 99.1 Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter Gaithersburg, Maryland, August 28, 2026, Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (the “Company” or “Shuttle”), today announced that the Company is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026 with the Securities and Exchange Commission by the required due date.” “The Company is required to submit a plan, by October 27, 2026, which outlines the steps the Company expects to take to regain compliance.”
“Our objective is to build a durable digital infrastructure platform rather than simply operate mining equipment,” said Ryan Trasolini, Co-CEO of Shuttle and a founder of United Dogecoin.
Stated in a supplied disclosure. Management reported: ““Our objective is to build a durable digital infrastructure platform rather than simply operate mining equipment,” said Ryan Trasolini, Co-CEO of Shuttle and a founder of United Dogecoin.” “In parallel, United Dogecoin remains focused on energizing its first ElphaPex miners as the units arrive at the Company’s hosting facility.”
Finalize integration and operational alignment following the merger with United Dogecoin to expand digital infrastructure capabilities.
Manage equity issuance, financing, and capital structure to support operations and strategic initiatives.
Over the trailing year it converted 0.84x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, Fed net liquidity, long-term interest rates, real (inflation-adjusted) rates (low R² over the window).
56 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Health Care names rated volatile grew net income 45% of the time over the next year (vs 45% for the rest of the cohort, n=10076).
Not investment advice. As of 2026-11-05.